Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) had its price objective reduced by investment analysts at Truist Financial from $17.00 to $15.00 in a research report issued on Monday, Benzinga reports. The firm presently has a "hold" rating on the business services provider's stock. Truist Financial's price target would indicate a potential upside of 24.79% from the company's previous close.
Separately, Barrington Research cut their price objective on Cross Country Healthcare from $21.00 to $19.00 and set an "outperform" rating on the stock in a research note on Thursday, August 8th. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, Cross Country Healthcare has an average rating of "Hold" and an average price target of $19.20.
Get Our Latest Stock Analysis on CCRN
Cross Country Healthcare Trading Down 6.6 %
NASDAQ CCRN traded down $0.85 on Monday, hitting $12.02. 783,299 shares of the company's stock were exchanged, compared to its average volume of 528,403. The stock has a 50-day moving average of $13.81 and a 200-day moving average of $14.93. The stock has a market cap of $417.98 million, a price-to-earnings ratio of 9.44, a P/E/G ratio of 2.37 and a beta of 0.63. Cross Country Healthcare has a 52 week low of $11.97 and a 52 week high of $23.64.
Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last posted its earnings results on Wednesday, July 31st. The business services provider reported $0.10 earnings per share for the quarter, missing analysts' consensus estimates of $0.14 by ($0.04). Cross Country Healthcare had a return on equity of 7.29% and a net margin of 0.54%. The company had revenue of $339.77 million for the quarter, compared to the consensus estimate of $334.75 million. During the same period in the previous year, the firm posted $0.69 EPS. The business's quarterly revenue was down 37.2% compared to the same quarter last year. As a group, analysts predict that Cross Country Healthcare will post 0.52 earnings per share for the current year.
Insider Activity
In other Cross Country Healthcare news, insider Karen Mote sold 13,829 shares of Cross Country Healthcare stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $17.08, for a total value of $236,199.32. Following the completion of the sale, the insider now directly owns 24,696 shares in the company, valued at approximately $421,807.68. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, VP Cynthia Ann Grieco sold 1,945 shares of the company's stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $17.21, for a total transaction of $33,473.45. Following the transaction, the vice president now owns 7,605 shares in the company, valued at approximately $130,882.05. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Karen Mote sold 13,829 shares of the stock in a transaction dated Friday, August 2nd. The stock was sold at an average price of $17.08, for a total transaction of $236,199.32. Following the transaction, the insider now directly owns 24,696 shares in the company, valued at $421,807.68. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 4.90% of the stock is owned by company insiders.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in CCRN. Boston Partners acquired a new stake in Cross Country Healthcare in the first quarter valued at approximately $2,511,000. BOKF NA acquired a new stake in Cross Country Healthcare in the 1st quarter valued at $247,000. Dana Investment Advisors Inc. grew its position in Cross Country Healthcare by 34.7% in the 2nd quarter. Dana Investment Advisors Inc. now owns 404,370 shares of the business services provider's stock valued at $5,596,000 after purchasing an additional 104,136 shares during the period. Orion Portfolio Solutions LLC increased its stake in Cross Country Healthcare by 22.8% during the 1st quarter. Orion Portfolio Solutions LLC now owns 75,819 shares of the business services provider's stock valued at $1,419,000 after purchasing an additional 14,101 shares in the last quarter. Finally, Sei Investments Co. raised its holdings in Cross Country Healthcare by 6.4% during the first quarter. Sei Investments Co. now owns 138,863 shares of the business services provider's stock worth $2,600,000 after buying an additional 8,362 shares during the last quarter. 96.03% of the stock is owned by institutional investors and hedge funds.
About Cross Country Healthcare
(
Get Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
See Also
Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.